How much is Saluda Medical worth in 2026?

Saluda Medical has a current valuation of N/A based on their PE Growth/Expansion round and secondary market data.

How much funding has Saluda Medical raised?

Saluda Medical has raised N/A in total funding across 3 funding rounds.

Saluda Medical

Therapeutic Devices

Saluda Medical valuation and funding history | Last updated: January 10, 2025 | 3 funding rounds

Current Valuation

N/A

As of January 10, 2025

Total Funding Raised

N/A

Across 3 rounds

Last Round

PE Growth/Expansion

$225.0M

Last Funding

Jan 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 10, 2025	PE Growth/Expansion	$225.0M	N/A	-
April 6, 2023	Later Stage VC (Series E)	$150.0M	N/A	-
March 2, 2022	Later Stage VC (Series C)	$124.4M	N/A	-

Valuation Analysis

Current Valuation Metrics

Saluda Medical is currently valued at N/A as of January 10, 2025.

Track Saluda Medical Valuation Updates

Get notified when Saluda Medical raises new funding or valuation changes

Explore More Data

Detailed analysis for Saluda Medical

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Saluda Medical's valuation history, funding rounds, and growth metrics.

No credit card required

What is Saluda Medical Worth in 2026?

Saluda Medical is a leading private company in the Therapeutic Devices sector. Track Saluda Medical's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Saluda Medical Valuation is Determined

Private company valuations like Saluda Medical's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.